USPTO serial 87833139
RELEAFIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with RELEAFIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Markham, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy J Benjamin
AMY J BENJAMIN BENJAMIN LAW PC111 EAST 14TH STREETSUITE 469NEW YORK, NY 10003Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software, downloadable application software and computer application software accessible through a web operating system for use by healthcare providers to design and monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medicine; computer software, downloadable application software and computer application software accessible through a web operating system to validate the safety and efficacy of medical cannabis as a therapeutic treatment for mental health and pain conditions; computer software, downloadable application software and computer application software accessible through a web operating system for generating clinical data respecting the safety, efficacy and patient compliance in the field of medical cannabis; computer software, downloadable application software and computer applications software accessible through a web operating system to aid and improve on patient compliance of prescribed medications; computer software, downloadable application software and computer application software accessible through a web operating system to allow patients to track and log symptoms, side effects, dosage and administration information for prescription medication; computer software, downloadable application software and computer application software accessible through a web operating system for providing medical and scientific research information in the field of pharmaceuticals and clinical trials | ACTIVE | — |
| 035 | Administration of consumer loyalty programs | ACTIVE | — |
| 042 | software as a service (SAAS) services featuring software for use by healthcare providers to design and monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medication; software as a service (SAAS) services featuring software to validate the safety and efficacy of medical cannabis as a therapeutic treatment for mental health and pain conditions; software as a service (SAAS) services featuring software for generating clinical data respecting the safety, efficacy and patient compliance in the field of medical cannabis; software as a service (SAAS) services featuring software to aid and improve on patient compliance of prescribed medications; software as a service (SAAS) services featuring software to allow patients to track and log symptoms, side effects, dosage and administration information for prescription medication; maintenance and technical support services for computer software which allows patients to track and log symptoms, side effects, dosage and administration information for prescription medication, and enables healthcare providers to design and monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medication; maintenance and technical support services for computer software which provides medical and scientific research information in the field of pharmaceuticals and clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 1, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 28, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 25, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2018 | NWAP | NEW APPLICATION ENTERED | — |